Wells Fargo Initiates Coverage of Guardant Health (GH) with Overweight Recommendation

Wells Fargo initiated coverage on Guardant Health (GH) with an Overweight rating on September 22, 2025, setting an average one-year price target of $61.27, which implies a 2.53% upside. The company projects annual revenue of $892 million, a 7.65% increase, alongside a non-GAAP EPS of -$5.08. While institutional ownership saw a 6.15% increase in total shares and an 8.96% rise in the number of reporting funds, the put/call ratio of 1.02 indicates a bearish outlook, with mixed activity among major institutional holders, as some reduced stakes while others increased their positions.

Analysis

Guardant Health (GH) presents a mixed investment profile following Wells Fargo's initiation of coverage with an 'Overweight' recommendation. While this analyst action is positive, the average one-year price target of $61.27 implies only a marginal 2.53% upside from its recent closing price, suggesting limited near-term appreciation potential according to consensus. The company's fundamentals show projected revenue growth of 7.65% to $892MM, but this is offset by continued unprofitability, with a projected non-GAAP EPS of -$5.08. Institutional sentiment appears divided; on one hand, the total number of funds holding GH increased by 8.96% and total institutional shares rose by 6.15%. However, a put/call ratio of 1.02 indicates bearish sentiment in the options market. Furthermore, activity among top holders is divergent: while Invesco significantly increased its stake by 21.47% and Vanguard also added shares, other major investors like Capital International, Baillie Gifford, and notably Deep Track Capital reduced their positions, with the latter cutting its holdings by a substantial 28.09%. This divergence suggests a lack of consensus among sophisticated investors regarding the company's outlook.

Key Decisions for Investors

• Despite the positive 'Overweight' rating from Wells Fargo, investors should be cautious given the minimal 2.53% upside implied by the average price target and the company's projected net loss.
• The conflicting signals between growing overall institutional ownership and bearish options sentiment (put/call ratio of 1.02) warrant a risk-aware approach; monitor for shifts in options activity for signs of changing sentiment.
• Note the divergent actions of major funds; the significant selling by Deep Track Capital is a red flag that contrasts with Invesco's increased position, suggesting investors should scrutinize the conviction and style of new institutional buyers before following suit.